WebN,N'N'-triethylenethiophosphoramide (ThioTEPA or thiotepa) is an alkylating agent used to treat cancer. ThioTEPA is an organophosphorus compound with the formula SP(NC 2 H 4) 3. It is an analogue of N,N',N''- triethylenephosphoramide . This molecule features tetrahedral phosphorus and is structurally akin to phosphate. WebThiotepa is an alkylating agent used to prevent graft rejection in stem cell transplantation …
DRUG NAME: Thiotepa - BC Cancer
Web第七章抗肿瘤药.pptx,Chapter 13 Antineoplastic Agents;Classification by mechanism; 13.1 Biological alkylating agents; Bioalkylating agents are cytotoxic drugs. In vivo, it is able to form a positive charged carbon-ion or other active electrophilic groups, and then the el WebCarmustine causes cross-links in DNA and RNA, leading to the inhibition of DNA synthesis, RNA production and RNA translation (protein synthesis). Carmustine also binds to and modifies (carbamoylates) glutathione reductase. This leads to cell death. ... Thiotepa: The risk or severity of adverse effects can be increased when Carmustine is ... cheap flights hawaii
An expanded-access clinical study of thiotepa (DSP-1958
WebNov 1, 2024 · The recommended dose of Thiotepa for injection for treatment of adenocarcinoma of the breast or ovary is 0.3 to 0.4 mg/kg intravenously. Doses should be given at 1 to 4 week intervals. Initially the higher dose in … WebNov 27, 2016 · English: Chemical synthesis of thiotepa. Created with ChemDoodle and Adobe Illustrator CC 2024. Date: 27 November 2016: Source: Own work: Author: Vaccinationist: Permission (Reusing this file) Public domain Public domain false false: This image of a simple ... WebThiotepa is also being studied in the treatment of other types of cancer and as part of a … cvs target hwy 100 st louis park